Nvidia-Backed CoreWeave's IPO Comes In Below Expectations At $40 Per Share
CoreWeave priced its initial public offering at
What Happened: The offering consists of 37.5 million shares, with CoreWeave selling 36.59 million and existing stockholders offloading 910,000 shares. The company granted underwriters a 30-day option to purchase up to an additional 5.63 million shares to cover over-allotments.
CoreWeave will trade under the ticker “CRWV” on the Nasdaq Global Select Market. The IPO is being led by
CoreWeave, an AI-focused cloud computing company, has seen exponential revenue growth, reaching
A key driver of CoreWeave's success is its strategic partnerships and customer base, which includes OpenAI,
See Also:
Why It Matters:
CoreWeave operates 32 data centers with over 250,000 GPUs dedicated to AI workloads. The company aims to expand its infrastructure, extend its enterprise reach, and pursue international growth, positioning itself as a leading AI hyperscaler amid soaring demand for compute power.
Read Next:
- Warren Buffett Told Students How He Got Rich Without Raising a Dime — Then Said: You’re Already ‘Living Better Than John D. Rockefeller’
Image via Shutterstock
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Related News
-
APi Group Names David Jackola CFO
MT Newswires - 18 minutes ago
-
UK expects to be hit by US tariffs this week, PM's spokesman says
Reuters - 18 minutes ago
-
Catholic shrine in Lourdes covers artwork by priest accused of abuse
Reuters - 19 minutes ago
-
WELL Health to Buy Majority Stake in HEALWELL AI Concurrent With Orion Health Closing
MT Newswires - 20 minutes ago
-
RBC Capital Adjusts Colgate-Palmolive Price Target to $97 From $98, Maintains Sector Perform Rating
MT Newswires - 21 minutes ago
-
Ravelin Properties REIT's Syndicate of Secured Lenders Assigns Credit Agreement to G2S2 Capital
MT Newswires - 23 minutes ago
-
US Dollar Falls Early Monday, Attention on March Employment Report, Powell
MT Newswires - 23 minutes ago
-
IDEAYA's Eye Cancer Therapy Receives Breakthrough Therapy Designation From FDA
MT Newswires - 23 minutes ago